In a recent study published in the journal Science Advances, a group of researchers investigated the immunogenicity and protective effectiveness of intranasally administered messenger Ribonucleic Acid ...
Lipid-based nanoparticles are a popular research area as a non-viral platform for delivering RNA molecules and include liposomes, lipoplexes, lipid nanoparticles and solid lipid nanoparticles. Using ...
Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...
Schematic illustration showing the classification of lipid‐based nanocarriers (LBNCs) (including liposomes, micelles, nanoemulsions, SLNs/NLCs, LNPs, BLNs, SRLNCs) and their targeted delivery to ...
Lipid nanoparticles (LNPs) have enormous potential for the delivery of genomic medicine. One obstacle, however, is the lack of effective ways to target specific cell types. In order to target lung ...
A recent study published in Small explored how cationic fusogenic liposomes can merge directly with cellular membranes to ...
The human papillomavirus (HPV) vaccine is a triumph of modern medicine—but it cannot eliminate an existing infection. Once HPV takes hold, no approved vaccines can stop its progression to cervical ...
The experimental nasal vaccine developed at Chiba University stimulated strong and long-lasting immune responses in animal models, activating tumor-fighting cells in the cervix and slowing cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results